季海峰,黄生富,姚成云.T1~2期鼻咽癌调强放疗后局部复发与临床转归分析[J].肿瘤学杂志,2020,26(10):875-878.
T1~2期鼻咽癌调强放疗后局部复发与临床转归分析
Local Recurrence and Outcome of T1~2 Nasopharyngeal Carcinoma after Intensity?鄄modulated Radiotherapy
投稿时间:2020-04-25  
DOI:10.11735/j.issn.1671-170X.2020.10.B005
中文关键词:  鼻咽肿瘤  T1~2 期  局部复发  挽救治疗
英文关键词:nasopharyngeal carcinoma  T1~2 stage  local recurrence  salvage therapy
基金项目:江苏省科技厅省重点研发计划(社会发展)(BE2019758)
作者单位
季海峰 如皋博爱医院 
黄生富 江苏省肿瘤医院&南京医科大学附属肿瘤医院&江苏省肿瘤防治研究所 
姚成云 江苏省肿瘤医院&南京医科大学附属肿瘤医院&江苏省肿瘤防治研究所 
摘要点击次数: 965
全文下载次数: 212
中文摘要:
      摘 要:[目的] 探讨T1~2 期鼻咽癌IMRT后局部复发及临床转归。[方法] 回顾性分析2005—2015年连续收治IMRT初治T1~2期鼻咽癌患者198例,分析复发危险因素、挽救治疗及转归情况。[结果] T1~2 期鼻咽癌IMRT后1、3、5年局部控制率分别为99.5%、95.9%和94.6%,总生存率分别为 100.0%、96.4%和90.8%。共14例患者出现局部复发,其中rT1~2 12例,复发部位包括咽隐窝7例(50.0%)、顶后壁5例(35.7%)、筛窦2例(14.3%);复发中位时间36个月(10~125个月)。挽救治疗中位随访36个月,其中7例行二程放疗,有3例再次复发;5例接受微创手术,均无再复发;2例行姑息化疗。6例患者病情进展死亡。[结论] T1~2 期鼻咽癌IMRT后局部复发率低,二程放疗疗效欠佳,放射后遗症较重。而手术治疗取得较好疗效同时避免了放射性并发症。T1~2 期鼻咽癌也应定期随访,尽早发现局部复发。
英文摘要:
      Abstract:[Objective] To analyze the local recurrence and clinical outcome of T1~2 nasopharyngeal carcinoma(NPC) after intensity-modulated radiotherapy(IMRT). [Methods] Clinical data of 198 consecutive T1~2 NPC patients treated with IMRT from 2005 to 2015 were retrospectively reviewed. Factors related to local recurrence,salvage treatment and outcome were analyzed. [Results] The 1-,3- and 5-year local control rates were 99.5%,95.9% and 94.6%,and the 1-,3- and 5-year overall survival was 100.0%,96.4% and 90.8%,respectively. Fourteen patients had local recurrence,of whom 12 were rT1~2. The recurrence sites were pharyngeal recess(7 cases,50.0%),the posterior parietal wall(5 cases,55.7%) and the ethmoid sinus(2 cases,24.3%). The median time to recurrence was 36 months(10~125 months). The median follow-up of salvage treatment was 36 months. Seven patients underwent second-course radiotherapy,and 3 patients relapsed. Five patients underwent minimally invasive surgery and no recurrence occurred. Two patients received palliative chemotherapy. Six patients died of progression. [Conclusion] T1~2 NPC patients have a low local recurrence rate after IMRT. Second-course radiotherapy is ineffective and the sequelae of radiation therapy are severe. Surgical treatment can improve the curative effect while avoiding radiation complications.T1~2 NPC should also be followed up regularly to detect local recurrence as early as possible.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器